Contraindicated (one)pentobarbital will lower the level or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is chargeable for the development and elimination of cariprazine's Energetic metabolites.
Keep track of Carefully (1)pentobarbital will lower the level or effect of benzhydrocodone/acetaminophen by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Caution when discontinuing CYP3A4 inducers which are coadministered with benzhydrocodone (prodrug of hydrocodone); plasma concentrations of hydrocodone might increase and may result in perhaps fatal respiratory despair.
pentobarbital will lower the level or outcome of quetiapine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the level or outcome of fludrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will decrease the extent or result of voriconazole by influencing hepatic enzyme CYP2C9/ten metabolism. Minor/Significance Unfamiliar.
pentobarbital will lower the extent or result of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Check Carefully (1)pentobarbital will decrease the level or outcome of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. CYP3A4 inducers haven't been researched, coadministration not advisable by manufacturer
Reserve concomitant prescribing of such prescription drugs in people for whom other procedure possibilities are insufficient. Limit dosages and durations to the minimum amount demanded. Watch carefully for signs of respiratory depression and sedation.
pentobarbital will lower the level or effect of tinidazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
fentanyl intranasal and pentobarbital both of those increase sedation. Prevent or Use Alternate Drug. Limit use to patients for whom different procedure choices are insufficient
Contraindicated (1)pentobarbital will decrease the level or outcome of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the extent or result of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Recommended atogepant dosage with concomitant usage of potent or average CYP3A4 inducers is thirty mg or 60 mg qDay.
pentobarbital will lower the extent or result of isavuconazonium sulfate by influencing hepatic/intestinal read more enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will reduce the extent or effect of exemestane by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. For patients obtaining exemestane with a powerful CYP3A4 inducer the proposed dose of exemestane is 50 mg daily after a food.